Agree, Umi. Nasdaq provides much more opportunity to use different strategies. Long term on the ASX for me is generally called escrow
It's a shame that investing in the outcomes of molecules is basically ~25% less COS than betting black or red on the roulette wheel. Happy to use a VC approach with shells, where downside from entry is usually minimal but VCs usually own 8-9 trainwrecks for every winner with bios and impossible to manage risk.
What are you looking at for 2019?
- Forums
- Commodities
- Biotech Analysts $4M pa
Biotech Analysts $4M pa, page-8
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online